Virus-like-particles (VLPs) of various papillomavirus (PV) types have been produced by expressing recombinant L1 proteins in eukaryotic cells. Although VLPs have the same ultrastructural appearance as native virions and their immunogenicity appears to be similar, their antigenicity has not been carefully evaluated. For this reason, the antigenicity of intact bovine PV type 1 (BPV-1) virions was compared with that of BPV-1 recombinant L1 VLPs by ELISA using a wellcharacterized panel of polyclonal and monoclonal antibodies generated against intact and denatured BPV-1 particles. The structural integrity of the authentic virions and recombinant VLPs was verified by electron microscopy. The specificity of antibodies raised against intact BPV-1 virions and their reactivity with VLPs revealed that the immunodominant, type-specific, conformational epitopes of intact virions were reproduced on VLPs. However, many monoclonal antibodies that define cross-reactive, non-conformational (linear) epitopes cryptic to the authentic BPV-1 virion tested positively when reacted with intact VLPs. One monoclonal antibody, which recognizes a BPV-1 and deer PV surface conformational epitope, did not react with VLPs.
Introduction
Papillomaviruses (PVs) are species-specific and anatomic site-restricted tumorigenic viruses (Baker, 1987; de Villiers, 1989; Pfeister, 1984) . In their natural host, they produce fibropapillomas or papillomas with productive infections occurring only in differentiating keratinocytes of low grade tumours. Virions have a non-enveloped capsid, 55 nm in diameter Crawford & Crawford, 1963; Pfeister, 1987) . PV capsids are icosahedral and are composed of 12 five-coordinated and 60 six-coordinated capsomeres arranged on a T= 7 surface lattice Finch & Klug, 1965) . The genome consists of double-stranded circular DNA, approximately 8 kb in size (Baker, 1987; Pfeister, 1984 Pfeister, , 1987 . PVs have two capsid proteins. The major capsid (L1) protein has a molecular mass of 55 kDa, representing about 80 % of the total viral protein (Pfeister, 1984) . The minor capsid (L2) protein migrates aberrantly at a molecular mass of 77 kDa in SDS-PAGE gels (Jin et * Author for correspondence. Fax + 1 202 687 8935. e-mail jensona@medlib.georgetown.edu al., 1989) . The density of complete PV virions in CsC1 has been shown to be 1.34 g/ml (Crawford & Crawford, 1963) .
Studies of the immunology and cell biology of papillomaviruses have been hampered by the lack of an in vitro system for replicating the virus. However, productive infections induced by PVs such as bovine PV type 1 (BPV-1) and human PV type 1 (HPV-1) have yielded quantities of virions sufficient to be characterized immunologically Lancaster & Olson, 1978; Lira et al., 1990; Yaegashi et al., 1991) . Although intact BPV-1 virions induce a type-specific, protective immune response against infection in the natural bovine host (Ghim et al., 1991; Jarrett et al., 1990) , the topographical locations of the neutralizing epitopes have not been defined. In anticipation of the development of subviral PV vaccines, it was suggested that the neutralizing immune response would target either type-specific conformational or nonconformational (linear) epitopes on the surface of virus particles (Cowsert et al., 1987) . Subsequently, it was demonstrated that conformational epitopes were targeted by high-titred, type-specific, neutralizing antibodies to BPV-1 (Ghim et al., 1991) . Recombinant L 1 proteins expressed in either the vaccinia 0001-3649 © 1996 SGM virus expression system (Hagensee et al., 1993; Zhou et al., 1993) or the baculovirus expression system (Christensen et al., 1994; Kirnbauer et al., 1992; Rose et al., 1994) have been shown to assemble into VLPs, composed of conformationally correct L1 proteins that reproduce neutralizing epitopes of authentic PV virions by mimicking the capsid ultrastructure (Ghim et aI., 1994; Hagensee et al., 1993 Hagensee et al., , 1994 Kirnbauer et al., 1992; Rose et al., 1994; Zhou et al., 1993) . BPV-1 VLPs induce high-titred neutralizing antibodies that can be measured by prevention of BPV-1-induced focus formation (FF) in immortalized murine cell lines (Kirnbauer et al., 1992) .
Recent studies have focused on the immunogenicity of virus-like particles (VLPs) and their possible use as subunit recombinant PV vaccines in the natural host (Breitburd et al., 1994; Ghim et al., 1995) . It has been assumed that intact BPV-1 VLPs are antigenically similar to intact BPV-1 virions (Kirnbauer et al., 1992) , which react only with antibodies that recognize surface epitopes (Cowsert et al., 1987) . In this study, using wellcharacterized polyclonal and monoclonal antibodies produced against intact and disrupted BPV-1 virions, we compared, by ELISA, the antigenicity of conformational and linear epitopes on BPV-1 VLPs with that of BPV-1 virions to determine the feasibility of using VLPs as antigenic substrates for tests such as serotyping.
Methods
Purification of BPV-1 virions. BPV-1 virions were purified from bovine fibropapillomas as described previously (Cowsert et al., 1987; Ghim et al., 1991) . Intact virions were stored as aliquots of stock solution at -80 °C until used.
Antibodies. A panel of monoclonal antibodies (MAbs) and polyclonal antibodies (PAbs) was used to compare the antigenicities of BPV-1 virions and VLPs. The antibodies have been previously characterized as recognizing either linear or conformational epitopes on the surface of intact BPV-1 virions or linear epitopes internal (cryptic) to the intact authentic capsid (Table 1) . MAbs AU-1 to AU-6 (Lim et al., 1990; Nakai et al., 1986) and 1H8 (Cowsert et al., 1987) recognize linear epitopes internal to the BPV-1 virion. AU-1, AU-2, AU-5 and 1H8 have been defined to the level of one amino acid by A BamHI-PstI fragment of BPV-1 containing the L1 gene was generated by PCR from p142-6. This fragment was cloned into the respective restriction endonuclease sites of pBlueBacII1, downstream of the polyhedrin promoter, creating pB1L1.
epitope mapping (Lira et al., 1990) . MAb 13D6 is cross-reactive with BPV-1 and deer PV (DPV), and recognizes external, non-neutralizing conformational epitopes (Cowsert et al., 1987) . MAb B1A1, kindly provided by N. D. Christensen, is type-specific and conformationally dependent, and neutralizes BPV-1 virions . Rabbit PAbs raised against disrupted BPV-I virions (Rdis, DAKO) recognize surface and cryptic linear epitopes. Rabbit sera raised against intact BPV-I virions (Rint) recognize surface conformational epitopes, some of which are neutralizing. The monoclonal antibody MAB45, which defines a type-specific linear epitope on the HPV-1 capsid (Yaegashi et al., 1991) , was used as a negative control.
Construction of BPV-1 L1 recombinant baculovirus.
The BPV-1 L1 open reading frame (from nt 5609 to 7161) was amplified by PCR from p142-6, which contains the full-length wild-type BPV-1 genome (Lambert & Howley, 1988) . The primers used were 5' GAC ATG GGA TCC GCC ACC ATG GCG TTG TGG CAA 3' (BamHI) and 5' GAC CTC CTG CAG TTT ATT AGG TGC AGT TGA 3' (PstI). This fragment was cloned into the BamHI and PstI sites of the baculovirus transfer vector pBlueBacIII (Invitrogen), creating pB1L1 ( Fig. 1 ). To produce recombinant baculovirus, pB1L1 was cotransfected with linearized wild-type AcMNPV DNA by cationic liposome-mediated transfection as instructed by the manufacturer (Transfection module; Invitrogen). The resulting recombinant baculovirus, rBacB1L1, was plaque purified using Grace's complete medium (Gibco/BRL) containing 1-25% SeaPlaque agarose (FMC Bioproducts) and X-Gal (for colour screening). High-titred recombinant baculovirus stocks were prepared as described by Invitrogen.
Immunofluorescence. BPV-1 L1 protein expression in Sf9 insect cells was verified using immunofluorescence (IF). For IF, cells were grown on coverslips and infected with rBacB1Ll or with wild-type baculovirus. At 72 h post-infection, the coverslips were fixed in cold acetone for 5 min and air dried. After rehydration in PBS, the coverslips were then incubated with Rint (diluted 1:100 in PBS) for 1 h at room temperature (RT), washed with PBS, and incubated with fluoresceinconjugated goat anti-rabbit IgG (H + L) (diluted 1 : 100 in PBS) under the same conditions. After the final washing, the slips were mounted in Elvanol and viewed with a fluorescent microscope (Olympus).
Purification of VLPs. Sf9 cells were cultured in supplemented Grace's medium containing 10 % fetal bovine serum and 0.1% Pluronic F-68 (Gibco/BRL) in spinner flasks. Cells (1.8 × 108) were infected with rBacB1L1 at an m.o.i, of 10 to 50. At 72 h post-infection, the infected cells were collected by centrifugation at 160 g for 10 min at 4 °C. The pellet was resuspended in hypotonic lysis buffer (10 mN-Tris-HC1, pH 8, 10 mM-NaC1, 1.5 mM-MgCI~), homogenized with 50 strokes in a tissue grinder and centrifuged at 9000 g for 20 min at 4 °C. The nuclei containing the VLPs were resuspended in Dulbecco's PBS containing MgCI~ and CaCI~ (D-PBS; Gibco/BRL) and sonicated for 1.5 rain at 9 W (Ultrasonic processor VC100; Sonics & Materials Inc.). The supernatant was loaded on top of a 40 % (w/v) sucrose-D-PBS cushion and centrifuged at 140000 g using an SW 55.1 Ti rotor for 2 h at 4 °C. The pellet was resuspended in D-PBS, sonicated for 10 s, and separated by centrifugation at 246000g for 20h in a CsC1 gradient (1.31~1-33 g/ml). The bands were collected separately and re-centrifuged for 2 h at 140000 g. The pellets were resuspended in D-PBS and the presence of VLPs was verified by electron microscopy.
Electron microscopy. BPV-1 virions and VLPs were immobilized on a 300 mesh Formvar/carbon-coated grid and negatively stained with 2% phosphotungstic acid (pH 6.8). VLPs and virions were observed with a transmission electron microscope (JEOL 100S) at a magnification of 30000 x and counted as previously described (Gorra et al., 1985) .
Immunoblot of BPV-1 virions and VLPs.
Protein samples were denatured in Laemmli sample buffer, heated at 95 °C for 5 min and separated on a 10 % SDS-PAGE gel. The separated proteins in the gel were electrically transferred to a nitrocellulose membrane. The membrane was saturated with immunoblot (IB) buffer (20 mM-Tris, 150 mM-NaC1, 0.4 % Tween 20) and incubated for 1 h at RT with Rdis (diluted 1 : 1500 in IB buffer). The membrane was washed with IB buffer and incubated with goat anti-rabbit IgG (H + L) labelled with alkaline phosphatase. After careful washing, substrate (naphthol AS-B1 phosphate and Fast Violet B; Sigma) dissolved in 100 mM-Tris buffer (pH 9"5) containing 1 mM-MgC12 was added until the bands became visible.
ELISA.
To compare the antigenicity of BPV-I virus particles and VLPs, these antigens were coated onto ELISA microplates (Immulon-2; Dynatech) for 1 h at 37 °C as either intact virions or VLPs (in PBS) or as disrupted virions or VLPs (in 150mM-NaC1, 0"25mM-flmercaptoethanol, 1% SDS, 20 mM-Tris, pH 7.4, and heated to 100 °C for 5 min). The antigens (BPV-1 virions and VLPs) were loaded to saturate the bottom of the wells (Table 2) . PBSA (PBS + 1% BSA) was used as a negative control to measure background. The wells were then washed with PBST (PBS, 0.05 % Tween 20) and saturated with 200 gl PBSA for 1 h at 37 °C. After washing, primary antibodies diluted 1 : 500 in PBSA, except Rint (1 : 1000) and MAB45 (culture supernatant), were added for 1 h at RT. After washing, the wells were incubated with goat anti-mouse or anti-rabbit IgG (H+ L) labelled with alkaline phosphatase for 1 h at RT. After the final washing with PBST, the wells were incubated for 10 min with substrate (Sigma 104 substrate tablets) and absorbance was measured at 410 nm (Dynatech MR700).
Results

Expression of BPV-1 L1 in Sf) cells
The L10RF of BPV-1 was cloned into wild-type AcMNPV. When BPV-1 L1 protein expression in Sf9 cells was examined by immunofluorescence, antibodies Rint and Rdis reacted strongly with the cells infected with the recombinant baculovirus, rBacB1L1, but not with cells infected with wild-type baculovirus (data not shown).
Purification and characterization of VLPs
Whereas virions banded at 1.29 g/ml (empty capsids) and 1-34 g/ml (full capsids), Sf9 cells infected with rBacB1L1 and harvested 72h post-infection yielded three distinct bands ranging from densities of 1.27-1.31 g/ml. Each band contained VLPs. The lightest band (1.27 g/ml) contained empty VLPs as viewed by electron microscopy. The heaviest band (1.31 g/ml) resembled complete or full virions, suggesting encapsidation of material from the infected insect cells. The intermediate band (1.29 g/ml) was frequently broad and VLPs appeared to contain partially encapsidated material. The buoyant density of each band appeared to depend primarily on the amount of encapsidated material in the respective VLPs. Capsomeres were identified in most preparations, particularly the intermediate band.
The antigenicity of capsomeres is unknown. VLPs from each band displayed the same antigenicity (data not shown) by ELISA using Rint antibodies. As viewed by electron microscopy, the surface topography of VLPs in all three bands had a similar ultrastructural appearance. The VLPs in the heaviest band had the same ultrastructural appearance as the BPV-1 virions (Fig. 2 a, b) , and, therefore, were used in the antigenicity studies. The L1 protein of the VLPs had a molecular mass of 55 kDa as shown by immunoblots with Rdis (Fig. 3) .
Comparison of reactivities of BPV-1 virions and VLPs against PAbs and MAbs
The L1 protein concentrations of virions and VLPs were quantified by immunoblot. As shown in Fig. 3 , comparison of the quantity of L1 protein in 0-5 ~tg protein of virion solution with that in 0.1 ~tg protein of VLP solution led to the conclusion that the L1 protein in the VLP solution was approximately two to three times more concentrated than in the virion solution. However, the numbers of authentic virus particles were higher than those of VLPs. The difference in the particle count of virions and VLPs with respect to the L1 protein concentrations was most likely due to increased L1 protein in the single and aggregated capsomeres (which were not counted) in the VLP preparations; capsomeres were not seen in virion preparations.
ELISA values indicating the reactivity of antibodies with saturated BPV-1 virions and VLPs were highly reproducible. Table 2 shows the representative ELISA values for the comparison of the antigenicity of virions and VLPs reactive with a panel of antibodies. It reveals that the most striking antigenic differences between virions and VLPs are detected using antibodies produced against denatured antigens. It also shows that BPV-1 virions and VLPs have the same reactivity by ELISA 
Comparison by E L I S A of reactivities of BPV-1 virions and VLPs with different antibodies
ELISA values were measured at 410 nm. Table  2 were not adjusted since the b a c k g r o u n d E L I S A values (reactivity of antibodies with PBSA) were less than 0.04. E L I S A values greater than 0-1 were considered positive as previously reported.
Discussion
VLPs are i m p o r t a n t for studying the immunogenicity and antigenicity o f authentic PV virions because virions are not recoverable in large quantities from most PVinduced lesions. In contrast to virions, VLPs can be p r o d u c e d in large quantities by various recombination techniques (Christensen et al., 1994; Hagensee et al., 1993 ; K i r n b a u e r et Rose et al., 1994) . After genotyping PV-induced lesions, the L 1 0 R F can be cloned into different eukaryotic expression vectors and expressed as VLPs that have the same ultrastructural a p p e a r a n c e as native virions (Christensen et al., 1994; G h i m et al., 1995; Hagensee et al., 1993 ; K i r n b a u e r et Rose et al., 1994) . These VLPs reproduce typespecific, neutralizing c o n f o r m a t i o n a l L1 protein epitopes that can be used as immunogens for vaccination against PV infection (Breitburd et al., 1994; G h i m et al., 1995;  K i r n b a u e r et al., 1992) . VLPs of BPV-1, HPV-11, Cottontail rabbit PV and canine oral PV induce neutralizing, conformationally dependent antibodies that can prevent infection and/or transformation of C127 cells (Kirnbauer et al., 1992) , murine xenografts (Christensen et al., 1994; Rose et aL, 1994) or animal hosts (Breitburd et al., 1994; Ghim et al., 1995) . Although the immunogenicity of a protein does not necessarily reflect its antigenicity, VLPs are candidates as antigenic substrates for detection of previous infection or for vaccination. For this reason, we compared the antigenicity of BPV-1 virions with that of recombinant L1 VLPs to determine if there were any significant differences between capsids of authentic BPV-1 virions and BPV-1 L1 VLPs.
PV type-specific conformational and linear epitopes are displayed on the surface of virions, whereas broadly cross-reactive linear epitopes are cryptic to the capsid (Cowsert et aL, 1987) . Cryptic epitopes can be identified in productive PV infections by immunocytochemical techniques and on synthetic peptide homologues, fusion proteins or denatured L1 proteins by ELISA or by immunoblotting (Viscidi & Shah, 1992) . In this study, well-characterized polyclonal and monoclonal antibodies produced against disrupted BPV-1 virions revealed that VLPs are antigenically different from authentic virions (Table 2) . Specifically, many cryptic epitopes that are not exposed on intact virions are exposed on intact VLPs. MAbs which recognize cryptic, non-conformational epitopes have previously been used as controls to ensure the fidelity of intact virions on ELISA (Cowsert et al., 1987; Ghim et aL, 1991) . Of these MAbs, AU-1 displays the strongest reactivity with BPV-1 VLPs. It is unlikely that the reactivity of VLPs with MAbs that recognize cryptic epitopes of virions is an artifact, since the experiment was repeated nine times. VLPs were reactive with MAb B1A1 and PAb Rint which recognize conformational epitopes. Moreover, the patterns of reactivities were consistent. The difference between the antigenicity of intact virions and homologous VLPs may be due to the increased flexibility of VLPs. Reactivity with capsomeres in VLP preparations is also a possibility. The presence of capsomeres may be due to incomplete self-assembly into VLPs or destabilization of VLPs during their extraction in vitro. Regardless, capsomeres may contain both conformational and linear epitopes that react with the paratopes of some of the antibodies used in this study.
PV linear surface epitopes are important because they are type-specific Cowsert et aL, 1987) . Antibodies against linear epitopes are preferentially used under different conditions: (1) serotyping of productive infections in formalin-fixed tissue and (2) antigen-capture ELISAs (Hagensee et al., 1993; Lim et al., 1990) .
Conformational epitopes are poorly reactive with antibodies in formalin-fixed tissue (unpublished observation). Moreover, conformationally dependent antibodies could possibly change the conformation of the capsid when used in antigen-capture ELISAs (Ghim & Jenson, 1993) . Identification of linear surface epitopes requires both disrupted and intact virions as the antigen (Cowsert et al., 1987) . Unfortunately, BPV-1 VLP preparations cannot be used to define surface linear epitopes in antigen-capture ELISAs for serotyping because these preparations are variably reactive with antibodies that recognize cryptic epitopes.
The humoral immune response against intact PV particles is primarily against immunodominant, conformationally dependent antibodies Christensen et al., , 1994 Ghim et al., 1991; Rose et al., 1994) . Surface or cryptic linear epitopes do not appear to be immunodominant for B cell mediated immunity in animals inoculated with intact PV virions or recombinant VLPs (A. B. Jenson, unpublished results). Although VLPs appear to be highly effective as an imnmnogen, it is uncertain what effect, if any, the apparent flexibility of VLPs will have on immune responses. It might be necessary to treat VLPs with a cross-linking fixative such as formalin to decrease their apparent flexibility or to identify their type-specific immunodominant neutralizing conformational epitopes in order to synthesize them in vitro for the serotyping of HPVs.
Not all conformational epitopes appear to be reproduced by VLPs. Of particular interest is MAb 13D6, which recognizes BPV-1 and DPV but not BPV-2 intact virions (Cowsert et al., 1987) , but was not reactive with BPV-1 VLPs. The most likely reason for this difference in reactivity is the flexibility of the BPV-1 L1 VLP when compared with authentic virions. However, it cannot be excluded that some conformational epitopes may be intermolecular, perhaps composed of amino acid residues contributed by both L1 and L2 proteins. Regardless, it demonstrates that VLPs may not have the same antigenicity as homologous virions.
